Sources | Names Used |
---|---|
CTRPv2 | 1S,3R-RSL-3 |
PharmacoGx | 1S,3R-RSL-3 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IL11RA | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | WASF3 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | HOXA7 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | PPM1B | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | DIDO1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | HERPUD2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | TIAL1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | HLA-DOA | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | TP53TG3C | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | AC136612.1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |